103D5R is a novel selective inhibitor of hif-1α, markedly decreasing hif-1α protein levels induced by hypoxia or cobaltous ions in a dose- and time-dependent manner References: Belozerov VE, Van Meir EG. Hypoxia inducible factor- a novel target for cancer therapy. Anticancer Drugs. 2005 Oct;16(9):901-9. Review. PubMed PMID: 16162966.
纯度:≥98%
CAS:773852-25-8